◀ Back to IRF6

CD1A — IRF6

Text-mined interactions from Literome

Arrighi et al., J Immunol 2001 (Dermatitis, Allergic Contact) : SB203580, an inhibitor of the p38 MAPK, but not the extracellular signal regulated kinase l/2 pathway blocker PD98059, inhibited the up-regulation of CD1a , CD40, CD80, CD86, HLA-DR, and the DC maturation marker CD83 induced by LPS and TNF-alpha
Xie et al., J Immunol 2003 : LPS not only impaired the morphology and reduced the yields of the cultured cells, but also inhibited the up-regulation of surface expression of CD1a , costimulatory and adhesion molecules
Lin et al., J Leukoc Biol 2007 : Treatment of PlGF-DC or classical-DC with PlGF resulted in the down-regulation of CD80, CD86, CD83, CD40, and HLA-DR expression, and CD1a was increased , as well as the inhibition of IL-12 p70, p40, IL-8, and TNF-alpha production in response to LPS stimulation